Voice of HCV from Asia Loon Gangte ITPC-South Asia
People 735,000 estimate HIV/HCV co infection in Asia. It has been estimated that there are up to 9 million IDUs in the Asia-Pacific region. In 2008, 4.7 million people in Asia were living with HIV An estimated 60% to 90% rate of HCV co-infection among IDU living with HIV/AIDS in Asia
Problem Testing for HCV is not widely available and accessible and not supported in any HIV programs Lack of HCV information & treatment education even among General population Lack of expertise among physician UNAFFORDABLE cost- Minimal people have access to treatment on HCV . Most resource poor/developing countries do not have Testing & Treatment Guideline Cost of Treatment, on request only*
Cost of Treatment China…….... USD 18,000 Thailand….…USD 17,828 Indonesia…..USD 18,000 Vietnam…….USD 28,000 India…………USD 16,000 approx. cost of Peg-INF & RBV for 48 weeks. The total cost of treatment including administration and monitoring approx USD 30,000 – 33,000
Why Peg.INF+RBV cost so high? Roche & Schering Plough hold the monopoly, PATENT on this drugs. No generic version = no competition.
We have to work on… “I withdrawn all my saving from the bank and cash all my wife’s jewelleries, to start my treatment from 13th July 2007 plus 4 of my friends support me financially ” .…manipur 50% of HIV infected IDU stated that they had already did Hepatitis C test, shocking fact which strike the process is most of HIV infected IDU thought that Hep C test is liver function test.......indonesia “Every NGO has a counselor, but they never inform or educate us about TB, Hep B and C ”….APN+ study “We have some options for HIV but for HCV we do not have anything. What are they (the govt.) waiting for? Are they waiting for us to die?...ITPC-India mapping. .